Transaction Overview - Hunan Warner Pharmaceutical Co., Ltd. approved a capital increase and introduction of strategic investors for its subsidiary, Shanghai Zhigen Pharmaceutical Technology Co., Ltd., with a total investment amount not exceeding 70 million RMB [1] - The investment is based on a pre-investment valuation of 400 million RMB, with the investors contributing a total of approximately 69.998684 million RMB [2] Transaction Progress - Zhigen Pharmaceutical has completed the industrial and commercial registration procedures for the capital increase and obtained a business license from the Shanghai Pudong New Area Market Supervision Administration [3] - The registered capital of Zhigen Pharmaceutical is 2.055572 million RMB, and it was established on November 23, 2021 [3]
湖南华纳大药厂股份有限公司 关于控股子公司增资扩股引入战略投资者暨关联交易的进展公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-09-07 23:40